Molecular Modelling and QSAR-Guided Design of Aminoquinoline-Pyrimidine Analogues Targeting Mutant Plasmodium falciparum DHFR-TS

Malaria remains a major public health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. The bifunctional dihydrofolate reductase-thymidylate synthase of Plasmodium falciparum (PfDHFR-TS) is an established antifolate target whose resistance-associated variants motivate ligand-directed discovery. This study combined molecular mechanics, Poisson-Boltzmann-based energy calculations, quantitative structure-activity relationship (QSAR) modelling, pharmacophore screening, in silico ADME prediction, and molecular dynamics to prioritise aminoquinoline-pyrimidine (AQPy) analogues. Twenty-three published AQPy compounds with whole-parasite antiplasmodial IC50 values were divided into a training set of 19 compounds and an external validation set of four compounds. Docking was based on the quadruple-mutant PfDHFR-TS structure (PDB 1J3K). The free-energy descriptor model showed a training-set coefficient of determination of approximately 0.96 and a four-compound external pIC50 root-mean-square error of approximately 0.23. A pharmacophore-guided design space produced 37 screened records corresponding to 33 distinct displayed compound identifiers. The most favourable modelled complexation-energy descriptors were associated with 15-106, 15-104, and 24-1. Calculated ADME descriptors and 200 ns molecular dynamics trajectories provided complementary information about the proposed binding poses and dynamic behaviour. Together, these results identify structural candidates for biochemical target testing and parasite-growth assays, while distinguishing the molecular-model rankings from experimentally measured inhibitory activity.

Authors

Institutions

Publication Details

Journal
Journal of Advances in Medical and Pharmaceutical Sciences
Published
2026-11-16
DOI
https://doi.org/10.9734/jamps/2026/v28i11911
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Molecular Modelling and QSAR-Guided Design of Aminoquinoline-Pyrimidine Analogues Targeting Mutant Plasmodium falciparum DHFR-TS

Issouf Fofana, Niaré Adama, Kré N’Guessan Raymond, Konaté Souleymane et al.
2 links
Journal of Advances in Medical and Pharmaceutical Sciences
Computational Drug Discovery Methods
article

Molecular Modelling and QSAR-Guided Design of Aminoquinoline-Pyrimidine Analogues Targeting Mutant Plasmodium falciparum DHFR-TS

Issouf Fofana, Niaré Adama, Kré N’Guessan Raymond, Konaté Souleymane, Soro Issouf, Kouakou Kouakou Jean-Louis
article en

Abstract

Malaria remains a major public health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. The bifunctional dihydrofolate reductase-thymidylate synthase of Plasmodium falciparum (PfDHFR-TS) is an established antifolate target whose resistance-associated variants motivate ligand-directed discovery. This study combined molecular mechanics, Poisson-Boltzmann-based energy calculations, quantitative structure-activity relationship (QSAR) modelling, pharmacophore screening, in silico ADME prediction, and molecular dynamics to prioritise aminoquinoline-pyrimidine (AQPy) analogues. Twenty-three published AQPy compounds with whole-parasite antiplasmodial IC50 values were divided into a training set of 19 compounds and an external validation set of four compounds. Docking was based on the quadruple-mutant PfDHFR-TS structure (PDB 1J3K). The free-energy descriptor model showed a training-set coefficient of determination of approximately 0.96 and a four-compound external pIC50 root-mean-square error of approximately 0.23. A pharmacophore-guided design space produced 37 screened records corresponding to 33 distinct displayed compound identifiers. The most favourable modelled complexation-energy descriptors were associated with 15-106, 15-104, and 24-1. Calculated ADME descriptors and 200 ns molecular dynamics trajectories provided complementary information about the proposed binding poses and dynamic behaviour. Together, these results identify structural candidates for biochemical target testing and parasite-growth assays, while distinguishing the molecular-model rankings from experimentally measured inhibitory activity.

Journal of Advances in Medical and Pharmaceutical SciencesVol. 28(11)
Université Nangui Abrogoua (CI), Institut National Polytechnique Félix Houphouët-Boigny (CI), Université Félix Houphouët-Boigny (CI)
Good health and well-being
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon